Post-stroke cognitive impairment (PSCI) is an increasingly prevalent sequel after stroke that may associate with poor functional outcome and increased risk of recurrent stroke. We aimed to explore the relationship between oxidative stress biomarkers and the presence of PSCI. 193 first-ever acute ischaemic stroke patients were consecutively enrolled in the current study. The oxidative stress biomarkers malondialdehyde (MDA) and 8-hydroxydeoxyquanosine (8-OHdG) were measured within 24 h after admission. Cognition function was evaluated by the Mini-Mental State Examination (MMSE) at 1 month after stroke. Serum levels of 8-OHdG and MDA were both significantly higher in the PSCI (p < 0.001) compared with the non-PSCI group. Both the serum levels of both 8-OHdG and MDA were negatively correlated with the MMSE score. Receiver operating characteristic curve analysis was used to evaluate 8-OHdG and MDA as markers of a high risk of PSCI and produced area under curve values of 0.700 and 0.793. Adjusted logistic regression showed that serum 8-OHdG and MDA levels remained as independent markers of PSCI. High serum levels of malondialdehyde and 8-OHdG are associated with the presence of PSCI at 1 month after stroke.Cognitive impairment is an increasingly prevalent sequel after stroke 1 , even in those with successful clinical recovery 2 . The diagnosis of post-stroke cognitive impairment (PSCI) deserves wide attention because the presence of cognitive impairment has been associated with poor functional outcome 2 and a higher risk of future stroke 3 . However, traditional known risk factors of PSCI, including older age, sex differences and a previous history of stroke 4 , are not readily amenable to treatment. Therefore, it is essential to identify pathophysiological mechanisms that may result in PSCI, especially in the early stage of stroke; however, research into the biochemical changes in PSCI is still not systematic and is lacking in both quality and quantity.Increasing evidence has demonstrated the vital role of oxidative stress pathways in the regulation of cognitive impairment related processes, including vascular inflammation 5 , neurodegeneration 6 , and blood-brain barrier (BBB) dysfunction 7 , all of which indicate the potential relationship between oxidative stress pathways and cognitive impairment.The oxidative stress pathway can produce oxidative damage of lipids and nucleic acids. 8-hydroxydeoxyquanosine (8-OHdG) and malondialdehyde (MDA) are common end-products of deoxyribonucleic acid (DNA) oxidation and lipid peroxidation, respectively, and can be detected in body fluid or brain in humans 8 . The systemic oxidative stress response to acute ischaemic stroke involves increases in 8-OHdG and MDA, which have also been associated with poor functional recovery 9 and mortality 10 . While higher peripheral blood levels of 8-OHdG 11 and MDA 12 have been associated with dementia, and some researchers have found that oxidative stress is related to cognition, without dementia or stroke 13 , the association between 8-OHdG...